Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $36,455,577.60. Following the transaction, the insider owned 13,450,547 shares in the company, valued at approximately $83,931,413.28. The trade was a 30.28% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Aveanna Healthcare Stock Performance
Shares of NASDAQ:AVAH traded up $0.15 on Friday, reaching $6.78. 510,328 shares of the company’s stock were exchanged, compared to its average volume of 1,345,372. The company has a fifty day moving average of $6.79 and a 200-day moving average of $7.73. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.73 and a twelve month high of $10.32. The company has a market capitalization of $1.48 billion, a price-to-earnings ratio of 5.74, a PEG ratio of 0.76 and a beta of 1.93. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.92 million for the quarter, compared to analyst estimates of $613.22 million. The company’s revenue was up 15.9% on a year-over-year basis. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.6 EPS for the current fiscal year.
Institutional Trading of Aveanna Healthcare
Wall Street Analysts Forecast Growth
AVAH has been the topic of several analyst reports. Truist Financial increased their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a research report on Friday, March 20th. BMO Capital Markets reduced their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. Finally, Weiss Ratings lowered shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $10.50.
Read Our Latest Stock Analysis on Aveanna Healthcare
Aveanna Healthcare Company Profile
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Articles
- Five stocks we like better than Aveanna Healthcare
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
-usd-0005-logo-1200x675.jpg){kind=logo}